Plasma levels of soluble Fas during normal pregnancy

Gynecologic and Obstetric Investigation

Volumn 51, Issue 2, 2001, Pages 96-98

  Hoshimoto, Kazunori ^a   Hayashi, Masatoshi ^a   Ohkura, Takeyoshi ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Fas Fas ligand system; Pregnancy; Soluble Fas

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ADULT; ANTIGEN DETECTION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOLOGICAL TOLERANCE; PREGNANCY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THIRD TRIMESTER PREGNANCY;

ADULT; APOPTOSIS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOCOMPETENCE; MEMBRANE GLYCOPROTEINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0035115674     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052901     Document Type: Article

References (25)

1. Antigen expression by trophoblast populations in the human placenta and their possible immunobiological relevance
2. The role of FasL-induced apoptosis in immune privilege
3. Monoclonal antibody-mediated tumor regression by induction of apoptosis
4. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
5. Purification and characterization of the Fas-ligand that induces apoptosis
6. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
7. A role for CD 95 ligand in preventing graft rejection
8. Fas ligand-induced apoptosis as a mechanism of immune privilege
9. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus
10. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
11. Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases
12. Expression of the Fas ligand in cells of T cell lineage
13. Fas ligand in human serum
14. Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis
15. Synthesis of T helper 2-type cytokines at the maternal-fetal interface
16. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion
17. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death
18. Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations
19. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis
20. Down-modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fas-ligand interaction
21. Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy
22. The thymus in pregnancy: The interplay of neural, endocrine and immune influences
23. Suppression of B lymphopoeisis during normal pregnancy
24. The immuno-stimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells
25. Highly sensitive ELISA for soluble Fas in serum: Increased soluble Fas in the elderly